Latest James Hardie Industries (ASX:JHX) News

James Hardie Industries reports a 34% jump in Q2 FY26 net sales driven by the AZEK acquisition and European growth, while grappling with margin pressures and integration costs.

James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.

James Hardie confirms key board changes and underscores its commitment to shareholder value amid strong integration progress with AZEK.

James Hardie Industries has reported preliminary Q2 FY26 results that surpass expectations, driven by resilient Siding & Trim sales and steady progress integrating AZEK. The company hints at a modestly improved outlook heading into the full fiscal year.

James Hardie Industries confirms its Q1 FY26 earnings met market expectations despite a challenging North American housing market, while revising its FY26 guidance following the AZEK acquisition.

James Hardie Industries reported a 9% decline in Q1 FY26 net sales to $900 million, while successfully completing its AZEK acquisition, setting the stage for expanded market reach and product offerings. The company adjusted its FY26 guidance to reflect softer North American demand but remains focused on long-term growth.

James Hardie Industries has completed its $8.4 billion acquisition of The AZEK Company, creating a powerhouse in exterior home and outdoor living solutions. The merger promises accelerated growth, significant synergies, and a broadened global footprint.

James Hardie Industries is set to terminate its American Depositary Share program following its merger with The AZEK Company and direct NYSE listing, simplifying its share structure for investors.

James Hardie Industries has successfully syndicated $3.5 billion in new credit facilities, providing robust financial backing for its planned merger with The AZEK Company Inc. This move significantly reduces prior bridge loan commitments and enhances the company’s financial flexibility.

KPMG's latest actuarial report reveals a slight increase in asbestos-related disease liabilities for former James Hardie entities, driven by a notable rise in mesothelioma claims and evolving actuarial assumptions.

James Hardie Industries plc reported a slight dip in FY25 sales and profits but met guidance, while announcing a transformative acquisition of The AZEK Company Inc to accelerate growth and synergies.

James Hardie has released its financial results for the fourth quarter and full year ended March 31, 2025, accompanied by a suite of detailed reports filed with both the ASX and SEC.